17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The Epigenetic Regulation of Nonhistone Proteins by SETD7: New Targets in Cancer

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Epigenetic modifications are essential mechanism by which to ensure cell homeostasis. One such modification is lysine methylation of nonhistone proteins by SETD7, a mono-methyltransferase containing SET domains. SETD7 methylates over 30 proteins and is thus involved in various classical pathways. As such, SETD7 has been implicated in both the basic functions of normal tissues but also in several pathologies, such as cancers. In this review, we summarize the current knowledge of SETD7 substrates, especially transcriptional-related proteins and enzymes, and their putative roles upon SETD7-mediated methylation. We focus on the role of SETD7 in cancers, and speculate on the possible points of intervention and areas for future research.

          Related collections

          Most cited references113

          • Record: found
          • Abstract: found
          • Article: not found

          Wnt/β-catenin signaling and disease.

          The WNT signal transduction cascade controls myriad biological phenomena throughout development and adult life of all animals. In parallel, aberrant Wnt signaling underlies a wide range of pathologies in humans. In this Review, we provide an update of the core Wnt/β-catenin signaling pathway, discuss how its various components contribute to disease, and pose outstanding questions to be addressed in the future. Copyright © 2012 Elsevier Inc. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Targeting HIF-1 for cancer therapy.

            Hypoxia-inducible factor 1 (HIF-1) activates the transcription of genes that are involved in crucial aspects of cancer biology, including angiogenesis, cell survival, glucose metabolism and invasion. Intratumoral hypoxia and genetic alterations can lead to HIF-1alpha overexpression, which has been associated with increased patient mortality in several cancer types. In preclinical studies, inhibition of HIF-1 activity has marked effects on tumour growth. Efforts are underway to identify inhibitors of HIF-1 and to test their efficacy as anticancer therapeutics.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              The complexity of NF-κB signaling in inflammation and cancer

              The NF-κB family of transcription factors has an essential role in inflammation and innate immunity. Furthermore, NF-κB is increasingly recognized as a crucial player in many steps of cancer initiation and progression. During these latter processes NF-κB cooperates with multiple other signaling molecules and pathways. Prominent nodes of crosstalk are mediated by other transcription factors such as STAT3 and p53 or the ETS related gene ERG. These transcription factors either directly interact with NF-κB subunits or affect NF-κB target genes. Crosstalk can also occur through different kinases, such as GSK3-β, p38, or PI3K, which modulate NF-κB transcriptional activity or affect upstream signaling pathways. Other classes of molecules that act as nodes of crosstalk are reactive oxygen species and miRNAs. In this review, we provide an overview of the most relevant modes of crosstalk and cooperativity between NF-κB and other signaling molecules during inflammation and cancer.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Genet
                Front Genet
                Front. Genet.
                Frontiers in Genetics
                Frontiers Media S.A.
                1664-8021
                22 June 2022
                2022
                : 13
                : 918509
                Affiliations
                [1] 1 Southern University of Science and Technology , Yantian Hospital , Shenzhen, China
                [2] 2 Guangdong Provincial Key Laboratory of Regional Immunity and Diseases , Department of Cell Biology and Genetics , Department of Pharmacy , Shenzhen University International Cancer Center , School of Medicine , The First Affiliated Hospital of Shenzhen University , Shenzhen Second People’s Hospital (Shenzhen Institute of Translational Medicine) , Shenzhen University , Shenzhen, China
                Author notes

                Edited by: Andy T. Y. Lau, Shantou University, China

                Reviewed by: Kangdong Liu, Zhengzhou University, China

                *Correspondence: You Zuo, 183401043@ 123456qq.com ; Duo Zheng, dzheng@ 123456szu.edu.cn
                [ † ]

                These authors have contributed equally to this work

                This article was submitted to Human and Medical Genomics, a section of the journal Frontiers in Genetics

                Article
                918509
                10.3389/fgene.2022.918509
                9256981
                35812730
                5b7a2f28-206e-4c27-bb88-1985de8a2e4d
                Copyright © 2022 Chiang, Yang, Zhu, Chen, Chen, Zuo and Zheng.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 12 April 2022
                : 27 May 2022
                Categories
                Genetics
                Mini Review

                Genetics
                setd7,epigentics,non-histone substrate,transcriptional factor,protein methylaiton
                Genetics
                setd7, epigentics, non-histone substrate, transcriptional factor, protein methylaiton

                Comments

                Comment on this article